✦ LIBER ✦

A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer

✍ Scribed by David Dodwell; Ignace Vergote

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Third-generation aromatase inhibitors in

✍ Jean-Marc A. Nabholtz; David M. Reese 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 517 KB

New aromatase inhibitors for the treatme

✍ P.Chr. de Jong; G.H. Blijham 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Second and third generation aromatase in

✍ J. Borne 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 160 KB

PCN35 A COST UTILITY ANALYSIS OF FULVEST

✍ M Pangali; A Christodoulopoulou; A Ardavanis; V Barbounis; E Galani; D Skarlos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Third generation aromatase inhibitors an

✍ J Bonte 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Early use of fulvestrant for the treatme

✍ E. Gutteridge; Agrawal; K.L. Cheung; P. Hyman-Taylor; A. Evans; J.F.R. Robertson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB